phentermine and tirzepatide 📢 ACP Obesity Guidelines 2026 are here. For the first time, semaglutide are recommended as co-first-line pharmacotherapy for obesity. #ACPGuidelines #ObesityMedicine #Semaglutide 🥇 THE NEW 4-TIER LADDER Tier 1: 💉 Top 5 Weight Loss Meds

Bariatric Surgery: Understanding the Limitations While GLP-1 agonists have revolutionized the approach to weight loss, its critical to understand that their efficacy has limitations, particularly in individuals with morbid obesity (Body Mass Index [BMI] 40 kg/m)

Higher Margins on Specialty Medications GLP-1 drugs are typically classified as specialty medications

Patients who are concerned about their weight or who have not achieved adequate results with current treatments should speak with their GP or a specialist weight management service

For more information, visit TB4-FRAG Integrative Peptides TB4-FRAG contains 250 mcg of a peptide fragment derived from Thymosin Beta 4

semaglutide 2.4 mg, 36.4%

Following transplantation, an early OGTT (e.g., at 1013 weeks) is recommended